BioCrystal

BioCrystal, Inc. was a biotechnology company primarily focused on developing innovative cell culture systems and cancer-related diagnostics and therapeutics. The company was best known for its proprietary OptiCell technology, a specialized cell culture device designed to optimize the growth, transport, and analysis of mammalian cells. Beyond its laboratory tools, BioCrystal pursued the development of monoclonal antibodies, such as BC-1, targeting tumor-associated antigens for the treatment of various solid tumors. Although the company was active in the late 1990s and early 2000s, it is no longer operational, and its technologies have largely been transitioned or discontinued.